Draerofit 50/100 Capsule

产品概览

About Draerofit 50/100

Draerofit 50/100 is a medication containing the active ingredient Salmeterol. Salmeterol is a long-acting β2 adrenergic receptor agonist (LABA) used in the treatment and prevention of asthma symptoms and control of chronic obstructive pulmonary disease (COPD) symptoms. Symptoms of bronchospasm include shortness of breath, wheezing, coughing and chest tightness.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler (FS MDPI) is indicated for the treatment of asthma in adult.
• Use only as directed on the product label or by a healthcare professional.
• Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

Salmeterol, the active ingredient in Draerofit 50/100, is the pharmacologically active substance of this product. 1 INDICATIONS AND USAGE Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler (FS MDPI) is indicated for the treatment of asthma in adult and pediatric patients aged 12 years and older. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Draerofit 50/100. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Draerofit 50/100 for extended periods without medical advice.